Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
FHTX
#3415
Foghorn Therapeutics Inc. Common Stock
4.870
0
USD
+0.41%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+0.41%
Aylık Değişim
-1.02%
6 aylık değişim
+19.36%
Yıllık Değişim
+19.36%
Önceki Kapanış
4.850
0
Open
4.870
0
Bid
Ask
Low
4.870
0
High
4.870
0
Hacim
3
Piyasalar
ABD Borsası
Sağlık Hizmetleri
FHTX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
55.61 M
55.74 M
56.53 M
56.55 M
58.7 M
—
Valuation ratios
Enterprise value
207.04 M
142.43 M
193.12 M
187.2 M
236.11 M
758.86 M
Price to earnings ratio
-2.99
-2.83
-4.2
-4.61
-4.58
-16.22
Price to sales ratio
11.46
9.01
12.01
12.35
11
44.37
Price to cash flow ratio
-2.58
-2.2
-3.14
-3.35
-3.95
-12.64
Price to book ratio
-5.69
-1.44
-1.35
-1.1
-3.13
-7.02
Enterprise value to EBITDA ratio
-2.08
-1.51
-2.18
-2.25
-2.84
-8.78
Profitability ratios
Return on assets %
-0.07
-0.07
-0.08
-0.08
-0.11
-0.34
Return on equity %
0.43
0.31
0.23
0.18
0.2
0.92
Return on invested capital %
-42.46
—
—
—
-90.05
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-840.51
-384.96
-279.17
-226.92
-258.22
-1 149.28
EBITDA margin %
-813.03
-371.07
-267.26
-215.88
-250.6
-1 104.81
Net margin %
-682.88
-316.43
-237.34
-194.39
-234.28
-982.45
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
3.73
3.16
2.62
2.16
2.73
10.68
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.02
0.03
0.04
0.05
0.14
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.45
-0.38
-0.33
-0.3
-0.35
-1.37
EBIT per share
-0.44
-0.36
-0.33
-0.29
-0.38
-1.37
EBITDA per share
-0.42
-0.35
-0.32
-0.28
-0.37
-1.32
Total debt per share
—
—
—
—
—
—
Cash per share
1.01
0.97
1.15
1.42
1.28
4.82
Net current asset value per share
4.55
3.59
3.24
2.92
2.59
12.34
Tangible book value per share
-0.83
-0.98
-1.22
-1.42
-1.72
-5.34
Working capital per share
3.33
2.45
2
1.57
1.64
7.67
Book value per share
-0.83
-0.98
-1.22
-1.42
-1.72
-5.34
Haberler
Foghorn, AACR toplantısında kanser verileri sunacak
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?
Citizens, Foghorn Therapeutics hissesi için hedef fiyatını korudu
Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress
Jefferies, Foghorn Therapeutics hissesi için tavsiyesini korudu
Jefferies reiterates Foghorn Therapeutics stock rating on pipeline data
Stifel, Foghorn Therapeutics hissesi için al önerisini yineledi
Stifel reiterates Foghorn Therapeutics stock rating at buy
Foghorn kazancı $0,02 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük
Foghorn earnings missed by $0.02, revenue fell short of estimates
Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates
Foghorn Therapeutics nakit pozisyonu 158,9 milyon dolar